Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Localized cutaneous scleroderma.

B R Krafchik1

  • 1University of Toronto, Hospital for Sick Children, Ontario, Canada.

Seminars in Dermatology
|March 1, 1992
PubMed
Summary
This summary is machine-generated.

Localized scleroderma in children, including morphea and linear types, presents with laboratory abnormalities. While often self-limiting, bone or facial involvement can cause significant impairment, necessitating careful treatment monitoring.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0·1% vs. clobetasol propionate 0·05% in childhood vitiligo.

The British journal of dermatology·2011
Same author

Acne.

Paediatrics & child health·2010
Same author

Eczema.

Paediatrics & child health·2010
Same author

Inflammatory linear verrucous epidermal nevus and arthritis: a new association.

The Journal of pediatrics·2001
Same author

Children with morphea have normal self-perception.

The Journal of pediatrics·2000
Same author

Vulvitis circumscripta plasmacellularis mimicking child abuse.

Journal of the American Academy of Dermatology·2000
Same journal

Genital herpes simplex virus and its treatment: focus on famciclovir.

Seminars in dermatology·1996
Same journal

Efficacy of famciclovir in the treatment of herpes zoster.

Seminars in dermatology·1996
Same journal

The pharmacological profile of famciclovir.

Seminars in dermatology·1996
Same journal

Epidemiology and management of postherpetic neuralgia.

Seminars in dermatology·1996
Same journal

Varicella-zoster virus: overview and clinical manifestations.

Seminars in dermatology·1996
Same journal

Advances in the management of herpesvirus infections. Introduction.

Seminars in dermatology·1996
See all related articles

Area of Science:

  • Pediatric Rheumatology
  • Dermatology
  • Immunology

Background:

  • Localized scleroderma in children encompasses morphea (trunk) and linear scleroderma (limbs, face, scalp).
  • Progressive systemic sclerosis is rare in children; transition from localized to progressive forms is exceptionally uncommon.
  • Associated laboratory findings include eosinophilia, positive antinuclear factor (ANF), and elevated immunoglobulin G (IgG).

Purpose of the Study:

  • To review the clinical presentation, laboratory findings, and treatment challenges of localized scleroderma in pediatric patients.
  • To highlight potential complications and the current understanding of scleroderma pathogenesis in children.

Main Methods:

  • Review of existing literature on pediatric localized scleroderma.
  • Discussion of clinical manifestations, diagnostic criteria, and treatment modalities.

Related Experiment Videos

  • Analysis of laboratory abnormalities and pathogenetic mechanisms.
  • Main Results:

    • Localized scleroderma is typically self-limiting, but bone involvement can cause functional impairment.
    • Facial lesions may be linked to underlying abnormalities and seizures.
    • Penicillamine is widely used but has side effects requiring renal function monitoring; other treatments show variable success.

    Conclusions:

    • The etiology of scleroderma remains unknown, though Borrelia titers have been implicated in some cases.
    • Effective treatment assessment is hindered by the lack of specific biomarkers.
    • Understanding the complex pathogenesis involving vascular, lymphokine, and connective tissue interactions is crucial for future therapies.